Laboratory of Clinical Pharmacology Copenhagen

Forside > Videnskabelige publikationer > 2012

2012

(327) Afzal S., Jensen S. A., Sorensen J. B., Henriksen T., Weimann A., Poulsen H. E. Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin. Cancer Chemother Pharmacol 2012 Feb;69(2):301-7.

(326) Egefjord L., Gejl M., Moller A., Braendgaard H., Gottrup H., Antropova O., Moller N., Poulsen H. E., Gjedde A., Brock B., Rungby J. Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer s disease - protocol for a controlled, randomized double-blinded trial. Dan Med J 2012 Oct;59(10):A4519.

(325) Jimenez-Solem E., Andersen J. T., Petersen M., Broedbaek K., Jensen J. K., Afzal S., Gislason G. H., Torp-Pedersen C., Poulsen H. E. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2(3).

(324) Jorgensen A., Jorgensen M. B., Poulsen H. E. [Stress and aging]. Ugeskr Laeger 2012 Jan 23;174(4):201-4.

(323) Meidahl Petersen K., Jimenez-Solem E., Andersen J. T., Petersen M., Brodbaek K., Kober L., Torp-Pedersen C., Poulsen H. E. beta-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open 2012;2(4).

(322) Petersen M., Andersen J. T., Jimenez-Solem E., Broedbaek K., Hjelvang B. R., Henriksen T., Frandsen E., Forman J. L., Torp-Pedersen C., Kober L., Poulsen H. E. Effect of the Arg389Gly beta(1)-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatment. Clin Exp Pharmacol Physiol 2012 Sep;39(9):779-85.

(321) Petersen M., Andersen J. T., Jimenez-Solem E., Broedbaek K., Afzal S., Nyegaard M., Borglum A. D., Stender S., Torp-Pedersen C., Kober L., Poulsen H. E. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial. Pharmacogenet Genomics 2012 Oct;22(10):709-15.

(320) Poulsen H. E., Specht E., Broedbaek K., Henriksen T., Ellervik C., Mandrup-Poulsen T., Tonnesen M., Nielsen P. E., Andersen H. U., Weimann A. RNA modifications by oxidation: a novel disease mechanism? Free Radic Biol Med 2012 Apr 15;52(8):1353-61.

(319) Sarac S. B., Rasmussen C. H., Afzal S., Thirstrup S., Jensen S. A., Colding-Jorgensen M., Poulsen H. E., Mosekilde E. Data-driven assessment of the association of polymorphisms in 5-Fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer. Basic Clin Pharmacol Toxicol 2012 Sep;111(3):189-97.

(318) Torp-Pedersen A., Jimenez-Solem E., Andersen J. T., Broedbaek K., Torp-Pedersen C., Poulsen H. E. Exposure to mebendazole and pyrvinium during pregnancy: a Danish nationwide cohort study. Infect Dis Obstet Gynecol 2012;2012:769851.

(317) Tveden-Nyborg P., Hasselholt S., Miyashita N., Moos T., Poulsen H. E., Lykkesfeldt J. Chronic vitamin C deficiency does not accelerate oxidative stress in ageing brains of guinea pigs. Basic Clin Pharmacol Toxicol 2012 Jun;110(6):524-9.

(316) Weeke P., Folke F., Gislason G. H., Lippert F. K., Olesen J. B., Andersson C., Wissenberg M., Poulsen H. E., Nielsen S. L., Kober L., Torp-Pedersen C. Hospital admissions and pharmacotherapy before out-of-hospital cardiac arrest according to age. Resuscitation 2012 May;83(5):584-90.

(315) Weeke P., Jensen A., Folke F., Gislason G. H., Olesen J. B., Andersson C., Fosbol E. L., Larsen J. K., Lippert F. K., Nielsen S. L., Gerds T., Andersen P. K., Kanters J. K., Poulsen H. E., Pehrson S., Kober L., Torp-Pedersen C. Antidepressant use and risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Clin Pharmacol Ther 2012 Jul;92(1):72-9.

(314) Weimann A., Broedbaek K., Henriksen T., Stovgaard E. S., Poulsen H. E. Assays for urinary biomarkers of oxidatively damaged nucleic acids. Free Radic Res 2012 Apr;46(4):531-40.